Peptide Tracker

Free weekly briefing

What changed in obesity and peptide trials this week, checked by a doctor.

Every Monday: new trials, status changes, results posted and what reads out next, across 2,033 trials and 36 drug families. Five minutes to read. Real sources linked.

  • The week's changes in one page
  • Published results with their limitations, not press releases
  • Estimated and actual dates kept apart

Get Monday's briefing

Free. No credit card.

Recent items from the tracker

NCT07855900 · Phase 3Survodutide: new 350-person obesity trial registeredPrimary completion 6 Nov 2029, estimated
NCT07855133 · Phase 1Switching from semaglutide to zenagamtideRecruiting · Novo Nordisk
Data noteSix cancer trials removed from pemvidutideA shared code name, ALT-801, had pulled them in.

Written and checked by

Dr Suzanne O'Connell

Doctor and electronic engineer, Trinity College Dublin: Medicine BA MB BCh BAO, Engineering BA BAI. Registered with the Irish Medical Council since 2008.

Research information for healthcare professionals and investors. Not medical advice and not investment advice.

Operated by BridgePoint Ventures SRL, Chișinău, Moldova.